Cancer Indicators - Clinton County
2007-2009
| Indicator | Data Links | 3 Year Total | County Rate | NYS Rate | Sig.Dif. | NYS Rate exc NYC | Sig.Dif. | County Ranking Group |
|---|---|---|---|---|---|---|---|---|
| All cancers | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 1,375 | 560.8 | 536.5 | No | 599.7 | Yes | 2nd |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 1,375 | 516.2 | 489.6 | No | 520.0 | No | 3rd |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 466 | 190.1 | 179.9 | No | 204.1 | No | 1st |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 466 | 175.8 | 163.0 | No | 173.9 | No | 2nd |
| Lip, Oral Cavity, and Pharynx Cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 26 | 10.6 | 11.5 | No | 12.7 | No | 1st |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 26 | 10.0 | 10.4 | No | 10.8 | No | 2nd |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 5 | 2.0* | 2.3 | No | 2.4 | No | 2nd |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 5 | 1.8* | 2.1 | No | 2.0 | No | 2nd |
| Colon and rectum cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 132 | 53.8 | 50.4 | No | 53.9 | No | 2nd |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 132 | 50.0 | 45.8 | No | 46.2 | No | 3rd |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 41 | 16.7 | 17.4 | No | 18.5 | No | 1st |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 41 | 15.8 | 15.7 | No | 15.7 | No | 2nd |
| Lung and bronchus cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 227 | 92.6 | 69.8 | Yes | 83.9 | No | 2nd |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 227 | 85.8 | 63.8 | Yes | 72.2 | Yes | 4th |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 169 | 68.9 | 46.9 | Yes | 57.2 | Yes | 3rd |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 169 | 63.5 | 42.8 | Yes | 49.0 | Yes | 4th |
| Female breast cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 163 | 135.9 | 147.1 | No | 164.9 | Yes | 1st |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 163 | 117.2 | 126.9 | No | 136.1 | No | 2nd |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 23 | 19.2 | 26.7 | No | 28.8 | No | 1st |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 23 | 15.9 | 21.7 | No | 22.2 | No | 1st |
| Crude late stage incidence per 100,000 | (Table) (Trend) (Map) | 9 | 7.5* | 8.0 | No | 8.3 | No | 3rd |
| Age-adjusted late stage incidence per 100,000 | (Table) (Trend) (Map) | 9 | 6.0* | 6.8 | No | 6.8 | No | 2nd |
| Cervix uteri cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 6 | 5.0* | 8.9 | No | 7.9 | No | 1st |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 6 | 4.9* | 8.3 | No | 7.4 | No | 1st |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 2 | 1.7* | 2.7 | No | 2.2 | No | 2nd |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 2 | 1.5* | 2.3 | No | 1.9 | No | 2nd |
| Ovarian cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 13 | 10.8 | 15.2 | No | 16.5 | No | 1st |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 13 | 9.0 | 12.9 | No | 13.4 | No | 1st |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 12 | 10.0 | 9.6 | No | 11.0 | No | 2nd |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 12 | 7.7 | 7.8 | No | 8.5 | No | 2nd |
| Prostate cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 212 | 169.2 | 169.1 | No | 186.0 | No | 2nd |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 212 | 167.1 | 166.9 | No | 171.2 | No | 3rd |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 11 | 8.8 | 18.5 | Yes | 19.2 | Yes | 1st |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 11 | 10.6 | 21.6 | Yes | 20.8 | Yes | 1st |
| Crude late stage incidence per 100,000 | (Table) (Trend) (Map) | 7 | 5.6* | 6.7 | No | 6.6 | No | 2nd |
| Age-adjusted late stage incidence per 100,000 | (Table) (Trend) (Map) | 7 | 6.4* | 7.2 | No | 6.6 | No | 2nd |
| Melanoma cancer mortality | ||||||||
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 8 | 3.3* | 2.3 | No | 3.1 | No | 3rd |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 8 | 3.2* | 2.1 | No | 2.7 | No | 3rd |
| Age-adjusted % of women 18 years and older with pap smear in past 3 years (2008-2009) | (Table) (Map) | N/A | 84.3 | 82.7 | No | 82.6 | No | 2rd |
| % of women 40 years and older with mammography screening in past 2 years (2008-2009) | (Table) (Map) | N/A | 82.4 | 79.7 | No | 81.9 | No | 1th |
N/A: Data not available
*: Fewer than 10 events in the numerator, therefore the rate is unstable
